Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PeriOlimel
- Development stage
- Unknown
- Lead developer
- Takeda
- Modality
- Small Molecules
- Administration
- Intravenous, Parenteral
01
Overview
PeriOlimel is a multi-nutrient parenteral nutrition emulsion developed and marketed by Baxter. It is presented in a three-compartment bag containing a lipid emulsion (a mixture of refined olive oil and refined soybean oil), amino acids, and glucose (dextrose), with or without electrolytes. Due to its low osmolarity, it is suitable for administration via both peripheral and central veins. It is indicated for nutritional support in adults and children when oral or enteral nutrition is impossible, insufficient, or contraindicated, providing essential energy, maintaining nitrogen balance, and correcting fatty acid deficiencies. In clinical settings, it is used to stabilize body weight and composition in patients with various conditions, including colorectal and biliopancreatic cancers.
- Brand names
- PeriOlimelOlimel periPERIOLIMEL N4EPERIOLIMEL 2.5% E
- Other names
- parenteral nutrition emulsion
Beyond the preview
Go deeper on PeriOlimel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PeriOlimel.